Patients with rheumatic diseases who live in underserved areas may benefit from virtual visits conducted jointly by rheumatologists and PCPs trained in recognizing and managing these conditions.
While advances in immunotherapy have dramatically improved cancer survival, unleashing the immune system can lead to a host of adverse reactions. How can patients pay less of a price?